[The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Schrama
E
E
Eusman
J P
JP
D001241:Aspirin / Q000008:administration & dosage*; D002544:Cerebral Infarction / Q000517:prevention & control*; D004176:Dipyridamole / Q000008:administration & dosage* / Q000009:adverse effects; D006261:Headache / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D012307:Risk Factors; D014665:Vasodilator Agents / Q000008:administration & dosage*
D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D004176:Dipyridamole; D001241:Aspirin